Smith & Nephew plc (LON:SN.) is favoured by institutional owners who hold 88% of the company [Yahoo! Finance]
Read the ruling [The New York Times]
Smith & Nephew SNATS (NYSE:SNN) was upgraded by analysts at Kepler Capital Markets to a "strong-buy" rating.
Smith & Nephew SNATS (NYSE:SNN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $36.00 to $34.00. They now have a "hold" rating on the stock.
Smith+Nephew comparative study1 shows PICO? sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT